The advent of effective pharmacotherapies, such as GLP-1RAs, has disrupted these narratives, reframing obesity treatment within a medical context
Review Article Abstract Introduction Retatrutide for Treatment of Obesity Retatrutide for Treatment of Type 2 Diabetes Effects of Retatrutide on Cardiovascular Risk Factors Safety of Retatrutide Effect of Retatrutide on Heart Rate Advantages of Retatrutide Limitations of Retatrutide Conclusions and Current Needs References Retatrutide for Treatment of Type 2 Diabetes In another phase 2 trial in the USA, retatrutide was evaluated for treatment of type 2 diabetes in comparison with subcutaneous dulaglutide (1.5mg/weekly) and placebo (Table 1) [4]
Better glucose handling reduces the blood sugar swings that trigger hunger and cravings
This cutting-edge therapy is backed by years of clinical research and offers a safe, highly targeted approach to improving both health and appearance at the cellular level
Eli Lilly has signalled intent to file with the FDA in the United States and the EMA in Europe after the TRIUMPH-1, 2, and 3 readouts
For this level of weight loss, expect appetite suppression to build gradually over the first 8-12 weeks, then sustain at a high level throughout the treatment period
